SK287273B6 - N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie - Google Patents

N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie Download PDF

Info

Publication number: SK287273B6
Authority: SK; Slovakia
Prior art keywords: pyridinyl; diazabicyclo; compound; covalent bond; pyrrole
Prior art date: 2000-04-27

Application number

SK1681-2002A

Other languages

English (en)

Slovak (sk)

Other versions

SK16812002A3 (sk

Inventor

Michael R. Schrimpf

Karin R. Tietje

Richard B. Toupence

Jianguo Ji

Anwer Basha

William H. Bunnelle

Jerome F. Daanen

Jennifer M. Pace

Kevin B. Sippy

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2001-04-27

Publication date

2010-05-07

2001-04-12 Priority claimed from US09/833,914 external-priority patent/US6809105B2/en

2001-04-27 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

2003-04-01 Publication of SK16812002A3 publication Critical patent/SK16812002A3/sk

2010-05-07 Publication of SK287273B6 publication Critical patent/SK287273B6/sk

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SK1681-2002A 2000-04-27 2001-04-27 N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie SK287273B6 (sk)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US55994300A	2000-04-27	2000-04-27
US09/833,914 US6809105B2 (en)	2000-04-27	2001-04-12	Diazabicyclic central nervous system active agents
PCT/US2001/013798 WO2001081347A2 (en)	2000-04-27	2001-04-27	Diazabicyclic central nervous system active agents

Publications (2)

Publication Number	Publication Date
SK16812002A3 SK16812002A3 (sk)	2003-04-01
SK287273B6 true SK287273B6 (sk)	2010-05-07

Family

ID=27072208

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SK10-2010A SK287658B6 (sk)	2000-04-27	2001-04-27	N-substituované diazabicyklické zlúčeniny, farmaceutické kompozície s ich obsahom a ich použitie
SK1681-2002A SK287273B6 (sk)	2000-04-27	2001-04-27	N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SK10-2010A SK287658B6 (sk)	2000-04-27	2001-04-27	N-substituované diazabicyklické zlúčeniny, farmaceutické kompozície s ich obsahom a ich použitie

Country Status (22)

Country	Link
EP (3)	EP2295437A1 (cs)
JP (2)	JP4981232B2 (cs)
KR (4)	KR100899950B1 (cs)
CN (3)	CN100430398C (cs)
AR (1)	AR030421A1 (cs)
AU (2)	AU6655901A (cs)
BG (2)	BG66151B1 (cs)
BR (1)	BR0107246A (cs)
CA (2)	CA2407094C (cs)
CZ (4)	CZ302072B6 (cs)
HK (1)	HK1054375A1 (cs)
HU (1)	HUP0300602A3 (cs)
IL (3)	IL152231A0 (cs)
MX (1)	MXPA02010594A (cs)
MY (3)	MY145722A (cs)
NO (1)	NO324250B1 (cs)
NZ (1)	NZ521734A (cs)
PE (1)	PE20011305A1 (cs)
PL (2)	PL358340A1 (cs)
SK (2)	SK287658B6 (cs)
TW (4)	TWI357903B (cs)
WO (1)	WO2001081347A2 (cs)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1235830E (pt)	1999-12-10	2004-04-30	Pfizer Prod Inc	Compostos de pirrolo¬2,3-d\|pirimidina como inibidores das proteina cinases
SE0100326D0 (sv) *	2001-02-02	2001-02-02	Astrazeneca Ab	New compounds
CA2506016C (en) *	2002-11-21	2009-03-17	Pfizer Products Inc.	3-amino-piperidine derivatives and processes for their preparation
US20040242641A1 (en) *	2003-05-27	2004-12-02	Buckley Michael J.	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US20050261348A1 (en) *	2004-05-21	2005-11-24	Buckley Michael J	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US7354937B2 (en)	2004-05-21	2008-04-08	Abbott Laboratories	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
US20050043407A1 (en) *	2003-08-22	2005-02-24	Pfizer Inc	Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US20050065178A1 (en) *	2003-09-19	2005-03-24	Anwer Basha	Substituted diazabicycloakane derivatives
US7399765B2 (en)	2003-09-19	2008-07-15	Abbott Laboratories	Substituted diazabicycloalkane derivatives
GB0322140D0 (en) *	2003-09-22	2003-10-22	Pfizer Ltd	Combinations
US8580842B2 (en)	2003-09-30	2013-11-12	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20050171079A1 (en)	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
EP1747206A1 (en)	2004-04-29	2007-01-31	Abbott Laboratories	Amino-tetrazoles analogues and methods of use
US7351833B2 (en)	2004-07-23	2008-04-01	Abbott Laboratories	(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
KR20080080206A (ko) *	2005-12-20	2008-09-02	아스트라제네카 아베	Ｇａｂａａ-수용체 조절제로서의 치환된 신놀린 유도체 및그의 합성 방법
US20070184490A1 (en) *	2006-01-17	2007-08-09	Marleen Verlinden	Neuronal nicotinic receptor ligands and their use
US7728031B2 (en)	2006-02-24	2010-06-01	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole derivatives
EP2083921A2 (en)	2006-09-04	2009-08-05	Neurosearch A/S	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
US8486979B2 (en)	2006-12-12	2013-07-16	Abbvie Inc.	1,2,4 oxadiazole compounds and methods of use thereof
US20080167286A1 (en)	2006-12-12	2008-07-10	Abbott Laboratories	Pharmaceutical compositions and their methods of use
US8076350B2 (en)	2006-12-22	2011-12-13	Abbott Laboratories	Spirocyclic azaadamantane derivatives and methods of use
UY30846A1 (es)	2006-12-30	2008-07-31	Abbott Gmbh & Amp	Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
CN101641355A (zh)	2007-03-23	2010-02-03	艾博特公司	氮杂金刚烷酯和氨基甲酸酯衍生物及其使用方法
CA2691782A1 (en)	2007-09-11	2009-03-19	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
US7935725B2 (en)	2007-10-31	2011-05-03	Janssen Pharmaceutica Nv	Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
JP5628043B2 (ja) *	2007-11-21	2014-11-19	アッヴィ・インコーポレイテッド	ビアリール置換ジアザビシクロアルカン誘導体
US8703775B2 (en)	2007-12-07	2014-04-22	AbbVie Deutschland GmbH & Co. KG	Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
EP2231644B1 (de)	2007-12-07	2014-01-15	AbbVie Deutschland GmbH & Co KG	5,6-Disubstitutierte Oxindol-Derivate und ihre Verwendung zur Herstellung eines Medikaments zur Behandlung von Vasopressin-abhängigen Erkrankungen
RU2484090C2 (ru)	2007-12-07	2013-06-10	Эбботт Гмбх Унд Ко.Кг	5-галогензамещенные производные оксиндола и их применение для лечения вазопрессинзависимых заболеваний
US8703774B2 (en)	2007-12-07	2014-04-22	AbbVie Deutschland GmbH & Co. KG	Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
EP2245028B1 (en)	2007-12-18	2012-02-22	Actelion Pharmaceuticals Ltd.	5-aminocyclylmethyl-oxazolidin-2-one derivatives
JP5530423B2 (ja)	2008-04-11	2014-06-25	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	ロイコトリエンａ４加水分解酵素の調節因子としてのチアゾロピリジン−２−イルオキシ−フェニル及びチアゾロピラジン−２−イルオキシ−フェニルアミン
US8148408B2 (en)	2008-05-09	2012-04-03	Abbott Laboratories	Selective substituted pyridine ligands for neuronal nicotinic receptors
US8263632B2 (en) *	2009-03-24	2012-09-11	Vertex Pharmaceuticals Incoporated	Aminopyridine derivatives having Aurora A selective inhibitory action
AU2010249041B2 (en)	2009-05-14	2014-11-13	Janssen Pharmaceutica Nv	Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolase
US9040568B2 (en)	2009-05-29	2015-05-26	Abbvie Inc.	Pharmaceutical compositions for the treatment of pain
US8268853B2 (en)	2009-06-25	2012-09-18	Abbott Laboratories	3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
DK2473049T3 (en)	2009-09-04	2019-04-01	Biogen Ma Inc	INHIBITORS OF BRUTON'S TYROSINKINASE
WO2011050200A1 (en)	2009-10-23	2011-04-28	Janssen Pharmaceutica Nv	Fused heterocyclic compounds as orexin receptor modulators
JP5848251B2 (ja) *	2009-10-23	2016-01-27	ヤンセンファーマシューティカエヌ．ベー．	オレキシン受容体調節因子としての縮合複素環式化合物
PT2491038T (pt)	2009-10-23	2016-07-14	Janssen Pharmaceutica Nv	Octahidropirrolo[3,4-c]pirrolos disubstituídos como modeladores de recetores de orexina
US9586962B2 (en)	2011-04-20	2017-03-07	Janssen Pharmaceutica Nv	Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
AR091273A1 (es)	2012-06-08	2015-01-21	Biogen Idec Inc	Inhibidores de pirimidinil tirosina quinasa
KR101655787B1 (ko)	2014-05-08	2016-09-22	대우조선해양 주식회사	선박의 하이브리드 공기조화시스템 및 그 방법, 그리고 이를 포함하는 선박 또는 해양구조물
KR20160021679A (ko)	2014-08-18	2016-02-26	대우조선해양 주식회사	극저온 환경의 장비용 히팅장치 및 방법 그리고 이를 구비하는 선박
US10000477B2 (en)	2014-10-31	2018-06-19	Indivior Uk Limited	Dopamine D3 receptor antagonist compounds
DK3426251T3 (da)	2016-03-10	2022-06-20	Janssen Pharmaceutica Nv	Fremgangsmåder til behandling af depression under anvendelse af orexin-2-receptorantagonister
US11174243B2 (en)	2016-07-21	2021-11-16	Sunesis Pharmaceuticals, Inc.	Succinate forms and compositions of Bruton's tyrosine kinase inhibitors
WO2019057123A1 (zh) *	2017-09-20	2019-03-28	杭州英创医药科技有限公司	作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物
GB201809295D0 (en)	2018-06-06	2018-07-25	Institute Of Cancer Res Royal Cancer Hospital	Lox inhibitors
EA202191356A1 (ru)	2018-11-14	2021-08-11	Янссен Фармацевтика Нв	Усовершенствованные способы синтеза для получения конденсированных гетероциклических соединений в качестве модуляторов рецептора орексина
WO2020239073A1 (zh) *	2019-05-30	2020-12-03	中国科学院上海药物研究所	一种并环化合物、其制备方法和用途
CN112047878B (zh) *	2020-10-15	2022-04-19	郑州猫眼农业科技有限公司	4-溴-6-氯吡啶-2-羧酸的制备方法
WO2024189472A1 (en)	2023-03-14	2024-09-19	Janssen Pharmaceutica Nv	Improved synthetic methods of making substituted pyrimidine intermediates for synthesis of orexin receptor modulators

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2079391T3 (es)	1989-04-17	1996-01-16	Bayer Ag	Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos.
NL9201810A (nl)	1992-10-19	1994-05-16	Dsm Nv	Werkwijze voor de omzetting van een olefine of een olefinemengsel.
NO301165B1 (no)	1992-12-25	1997-09-22	Daiichi Seiyaku Co	Bicykliske aminderivater og antibakterielle midler inneholdende disse
US5817679A (en) *	1993-04-01	1998-10-06	University Of Virginia	7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US5478939A (en) *	1994-07-20	1995-12-26	American Cyanamid Company	(R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
US5472958A (en)	1994-08-29	1995-12-05	Abbott Laboratories	2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
US5585388A (en)	1995-04-07	1996-12-17	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acetylcholine receptors
PT842178E (pt) *	1995-07-28	2001-08-30	Abbott Lab	Furopiridina tienopiridina pirrolopiridina e compostos relacionados de pirimidina piridazina e triazina uteis no controlo da transmissao sinaptica quimica
GB9519558D0 (en) *	1995-09-26	1995-11-29	Merck Sharp & Dohme	Therapeutic agents
JPH09172344A (ja)	1995-12-19	1997-06-30	Murata Mfg Co Ltd	圧電共振子
US5733912A (en)	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
DE69811070T2 (de) *	1997-05-30	2003-10-02	Neurosearch A/S, Ballerup	9-azabicyclo(3.3.1)non-2-ene und nonanderivate als liganden der nicotinergen rezeptoren
IL132437A0 (en) *	1997-05-30	2001-03-19	Neurosearch As	8-Azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
GB9722343D0 (en) *	1997-10-22	1997-12-17	British Telecomm	Distributed virtual environment
PT1027336E (pt) *	1997-10-27	2005-01-31	Neurosearch As	Heteroarildiazacicloalcanos como ligandos colinergicos de receptores nocotinicos de acetilcolina
US6632823B1 (en) *	1997-12-22	2003-10-14	Merck & Co., Inc.	Substituted pyridine compounds useful as modulators of acetylcholine receptors
DK1068208T3 (da) *	1998-04-02	2003-09-01	Targacept Inc	Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem
PA8474101A1 (es) *	1998-06-19	2000-09-29	Pfizer Prod Inc	Compuestos de pirrolo [2,3-d] pirimidina
JP2000026408A (ja)	1998-07-02	2000-01-25	Dai Ichi Seiyaku Co Ltd	対掌体的に純粋なピロリジン誘導体、その塩、それらの製造方法
US6804251B1 (en)	1998-11-12	2004-10-12	Broadcom Corporation	System and method for multiplexing data from multiple sources
FR2786769B1 (fr) *	1998-12-04	2002-10-25	Synthelabo	Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
ES2209825T3 (es) *	1999-01-29	2004-07-01	Abbott Laboratories	Derivados diazabiciclicos utiles como ligandos del receptor nicotinico de la acetilcolina.
ATE261448T1 (de) *	1999-05-04	2004-03-15	Neurosearch As	Heteroaryl diazabicycloalkene, deren herstellung und verwendung
WO2000071534A1 (en) *	1999-05-21	2000-11-30	Abbott Laboratories	Heterocyclic substituted aminoazacycles useful as central nervous system agents
JP2003516988A (ja) *	1999-12-14	2003-05-20	ニューロサーチ、アクティーゼルスカブ	新規ヘテロアリール−ジアザビシクロアルカン類

2001
- 2001-04-26 MY MYPI20055633A patent/MY145722A/en unknown
- 2001-04-26 MY MYPI20011984A patent/MY137020A/en unknown
- 2001-04-27 WO PCT/US2001/013798 patent/WO2001081347A2/en active Application Filing
- 2001-04-27 CN CNB018117112A patent/CN100430398C/zh not_active Expired - Fee Related
- 2001-04-27 SK SK10-2010A patent/SK287658B6/sk not_active IP Right Cessation
- 2001-04-27 HU HU0300602A patent/HUP0300602A3/hu unknown
- 2001-04-27 CZ CZ20080677A patent/CZ302072B6/cs not_active IP Right Cessation
- 2001-04-27 PL PL01358340A patent/PL358340A1/xx unknown
- 2001-04-27 EP EP10177411A patent/EP2295437A1/en not_active Withdrawn
- 2001-04-27 KR KR1020027014385A patent/KR100899950B1/ko not_active IP Right Cessation
- 2001-04-27 CZ CZ20090553A patent/CZ302038B6/cs not_active IP Right Cessation
- 2001-04-27 EP EP01944118A patent/EP1284976A2/en not_active Withdrawn
- 2001-04-27 KR KR1020087031655A patent/KR100961406B1/ko not_active IP Right Cessation
- 2001-04-27 CN CN2010102450796A patent/CN101935322A/zh active Pending
- 2001-04-27 BR BR0107246-3A patent/BR0107246A/pt not_active IP Right Cessation
- 2001-04-27 MX MXPA02010594A patent/MXPA02010594A/es active IP Right Grant
- 2001-04-27 EP EP10177450A patent/EP2298775A1/en not_active Withdrawn
- 2001-04-27 PE PE2001000385A patent/PE20011305A1/es not_active Application Discontinuation
- 2001-04-27 SK SK1681-2002A patent/SK287273B6/sk not_active IP Right Cessation
- 2001-04-27 JP JP2001578437A patent/JP4981232B2/ja not_active Expired - Fee Related
- 2001-04-27 AU AU6655901A patent/AU6655901A/xx active Pending
- 2001-04-27 CA CA002407094A patent/CA2407094C/en not_active Expired - Fee Related
- 2001-04-27 CA CA002683045A patent/CA2683045A1/en not_active Abandoned
- 2001-04-27 NZ NZ521734A patent/NZ521734A/en not_active IP Right Cessation
- 2001-04-27 CN CN2012103509141A patent/CN102863441A/zh active Pending
- 2001-04-27 KR KR1020097021390A patent/KR100947188B1/ko not_active IP Right Cessation
- 2001-04-27 IL IL15223101A patent/IL152231A0/xx not_active IP Right Cessation
- 2001-04-27 KR KR1020097010331A patent/KR100947187B1/ko not_active IP Right Cessation
- 2001-04-27 CZ CZ20023765A patent/CZ301324B6/cs not_active IP Right Cessation
- 2001-04-27 AU AU2001266559A patent/AU2001266559C1/en not_active Ceased
- 2001-04-27 PL PL398491A patent/PL398491A1/pl unknown
- 2001-04-27 AR ARP010101990A patent/AR030421A1/es active IP Right Grant
- 2001-04-27 CZ CZ20100538A patent/CZ302795B6/cs not_active IP Right Cessation
- 2001-05-22 TW TW097145362A patent/TWI357903B/zh not_active IP Right Cessation
- 2001-05-22 TW TW095100404A patent/TWI323733B/zh not_active IP Right Cessation
- 2001-05-22 TW TW100130949A patent/TW201141871A/zh unknown
- 2001-05-22 TW TW090110172A patent/TWI311137B/zh not_active IP Right Cessation
2002
- 2002-10-24 NO NO20025107A patent/NO324250B1/no not_active IP Right Cessation
- 2002-11-21 BG BG107303A patent/BG66151B1/bg unknown
2003
- 2003-07-08 HK HK03104885.7A patent/HK1054375A1/zh unknown
2005
- 2005-03-07 MY MYPI20094589A patent/MY168244A/en unknown
2006
- 2006-08-06 IL IL177316A patent/IL177316A/en not_active IP Right Cessation
2009
- 2009-12-29 IL IL203035A patent/IL203035A/en not_active IP Right Cessation
2010
- 2010-03-17 BG BG110620A patent/BG110620A/bg unknown
2011
- 2011-09-15 JP JP2011202172A patent/JP2012041349A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
MY145722A (en)	2012-03-30
TWI357903B (en)	2012-02-11
IL177316A (en)	2010-06-30
CN1440410A (zh)	2003-09-03
TWI323733B (en)	2010-04-21
CZ302038B6 (cs)	2010-09-15
IL152231A0 (en)	2003-05-29
KR100899950B1 (ko)	2009-05-28
TW200909432A (en)	2009-03-01
WO2001081347A3 (en)	2002-01-31
HUP0300602A2 (hu)	2003-06-28
NO324250B1 (no)	2007-09-17
CZ302795B6 (cs)	2011-11-16
HUP0300602A3 (en)	2005-12-28
SK16812002A3 (sk)	2003-04-01
CA2407094C (en)	2009-11-17
KR20090071654A (ko)	2009-07-01
JP4981232B2 (ja)	2012-07-18
CZ302072B6 (cs)	2010-09-29
EP1284976A2 (en)	2003-02-26
KR100961406B1 (ko)	2010-06-09
KR100947187B1 (ko)	2010-03-12
CZ20023765A3 (cs)	2003-02-12
PL358340A1 (en)	2004-08-09
CN100430398C (zh)	2008-11-05
TWI311137B (en)	2009-06-21
BG66151B1 (bg)	2011-08-31
JP2003531210A (ja)	2003-10-21
HK1054375A1 (zh)	2003-11-28
NO20025107L (no)	2002-12-19
MY168244A (en)	2018-10-15
TW200617013A (en)	2006-06-01
TW201141871A (en)	2011-12-01
SK287658B6 (sk)	2011-05-06
NZ521734A (en)	2004-10-29
CN102863441A (zh)	2013-01-09
AU2001266559B2 (en)	2005-03-03
MXPA02010594A (es)	2003-05-14
KR20090013833A (ko)	2009-02-05
IL177316A0 (en)	2006-12-10
KR20090121385A (ko)	2009-11-25
PL398491A1 (pl)	2012-06-04
BG107303A (bg)	2003-07-31
CA2407094A1 (en)	2001-11-01
AU2001266559C1 (en)	2005-11-17
KR100947188B1 (ko)	2010-03-12
AR030421A1 (es)	2003-08-20
EP2298775A1 (en)	2011-03-23
WO2001081347A2 (en)	2001-11-01
IL203035A (en)	2010-12-30
JP2012041349A (ja)	2012-03-01
KR20020093955A (ko)	2002-12-16
BR0107246A (pt)	2002-10-01
PE20011305A1 (es)	2001-12-31
CN101935322A (zh)	2011-01-05
NO20025107D0 (no)	2002-10-24
AU6655901A (en)	2001-11-07
EP2295437A1 (en)	2011-03-16
CZ301324B6 (cs)	2010-01-13
CA2683045A1 (en)	2001-11-01
BG110620A (bg)	2010-07-30
MY137020A (en)	2008-12-31

Publication	Publication Date	Title
US8119635B2 (en)	2012-02-21	Diazabicyclic central nervous system active agents
CA2407094C (en)	2009-11-17	Diazabicyclic central nervous system active agents
AU2001266559A1 (en)	2002-01-24	Diazabicyclic central nervous system active agents
AU773795B2 (en)	2004-06-03	Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands

Legal Events

Date	Code	Title	Description
2015-01-07	MM4A	Patent lapsed due to non-payment of maintenance fees	Effective date: 20140427